Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

273.80
Delayed Data
As of Feb 05
 +1.35 / +0.50%
Today’s Change
237.50
Today|||52-Week Range
340.34
-12.38%
Year-to-Date

Today’s Trading

Previous close272.45
Today’s open270.83
Day’s range270.52 - 277.68
Volume2,386,590
Average volume (3 months)4,290,956
Market cap$107.9B
Dividend yield--
Data as of 4:02pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+10.32%
Earnings growth (next 5 years)+10.02%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.77-1.90%
BMYBristol-Myers Squibb-0.07-0.12%
GSKGlaxoSmithKline-0.22-0.54%
NVONovo Nordisk-0.75-1.51%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$3.34
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers